The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
SELLAS Life Sciences (NASDAQ:SLS) traded sharply lower on Thursday after the New York-based biotech released interim results from its Phase 3 REGAL trial for its lead asset, galinpepimut-S (GPS ...
In its current form, SLS largely duplicates capacity available elsewhere at far lower cost. It consumes money and engineering resources that would better be spent developing improved deep space ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results